Approval · Notice of Compliance 19246 · 2017
DIPROSONE: Notice of Compliance 19246
Issued May 3, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19246
- Date
- May 3, 2017
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change3 in the drug product manufacturing and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIPROSONE | Not yet assigned | — |
Medicinal ingredients
- BETAMETHASONE DIPROPIONATE 0.05 PER